Hirslanden Clinique La Colline Adopts Medacta’s Efficiency KneePack: the New Gold Standard in Resource Optimization and Knee Replacement Procedure Management
27.6.2017 20:11 | Business Wire
Hirslanden Clinique La Colline, an internationally renowned clinic in Geneva and part of the first Swiss private clinic group Hirslanden, has optimized instrument management and implant stock for its total knee replacement (TKR) procedures by introducing Medacta’s Efficiency KneePack as the new standard in its practice. This advanced solution has helped Clinique La Colline to improve its supply chain and TKR procedure workflow, reducing the resources needed to manage procedures and enabling an even stronger focus on surgeons’ needs and patients’ wellbeing.
“I was already using Medacta’s MyKnee Patient-Specific cutting blocks, which have helped me achieve higher dependability with greater ease and comfort of use in every case,” said Dr. med. Jean-Philippe Corsat.
“The Single Use Instruments, delivered brand new and unworn every time, have been a great addition,” added Dr. med. Marc Saudan. “I didn’t have to change my technique at all; after a few cases, I was completely used to them.”
Delivered sterile and ready for use, the Efficiency KneePack is the ultimate solution to implant Medacta’s GMK® Primary or GMK® Sphere in a TKR procedure. The Efficiency KneePack includes femur and tibia implants, MyKnee® Patient-Matched cutting blocks and GMK® Efficiency single use instruments.
“Thanks to Medacta’s Efficiency KneePack, we have drastically streamlined our logistic workflow,” said André Joyeusaz, a Hirslanden Clinique La Colline logistics department representative. “Instrumentation sets and implants are delivered just a few days before surgery, limiting the stock here at the surgical unit. Everything we need is packaged together, minimizing any source of error and helping us more swiftly to manage the logistics. This is very important on busy days. Any problem related to lost or worn out instruments has been eliminated, including paperwork.”
“The first thing that I noticed was that these instruments are much lighter than the metal ones,” said Veronique Guerraz, a perioperative nurse at the clinic. “They are also very intuitive to assemble and require less thought process to set them up. I can quickly find the instruments needed at each surgical step thanks to their different colors and the organized layout. The packaged sets arrive already sterile and organized, so we do not have to check them before surgery; we can just open the blisters and start using the instruments.”
In order to facilitate the best possible outcomes, Medacta utilizes pre-operative computer-based surgical planning software to deliver exactly what is needed for the surgical procedure, including the Efficiency Instruments and implants. This minimizes inventory constraints and provides the necessary inventory to complete the specific surgical procedure.
“It is Medacta’s mission to address surgeon and hospital needs with advanced technologies that encourage patient wellbeing and healthcare system sustainability,” said Francesco Siccardi, Executive Vice President of Medacta International. “The Efficiency KneePack embodies this as it addresses pain points at every level. We believe it will become the gold standard for clinics and ambulatory surgical centers looking to optimize their resources.”
Clinique La Colline is the first center to use Medacta’s Efficiency KneePack, and other centers are now following suit.
About Medacta ® International
Medacta® International is a world leading manufacturer of orthopedic implants, neurosurgical systems, and instrumentation. Medacta’s revolutionary approach and responsible innovation have resulted in standard of care breakthroughs in hip replacement with the AMIS® system and total knee replacement with MyKnee® patient matched technology. Over the last 10 years, Medacta has grown dramatically by taking a holistic approach and placing value on all aspects of the care experience from design to training to sustainability. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 30 countries.
To learn more about Medacta International, please visit: https://www.medacta.com.
for Medacta International
Jill Bongiorni, 516-729-2250
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
PacSci EMC Competes on National Stage as NASA iTech Innovation Competition Finalist20.7.2017 21:45 | Pressemelding
PacSci EMC recently participated as a finalist in NASA’s second iTech Forum, competing to have their innovative idea selected as one of the top 10 in a yearlong initiative to find and foster innovative solutions with the potential to benefit NASA and the nation in the future. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170720006386/en/ Douglas Terrier, Acting Chief Technologist, NASA presents Peter Current, Steve Nelson, and Bret Omsberg with a certificate recognizing “PacSci EMC as a top 10 finalist of NASA iTech’s Cycle 2 on July 13, 2017.” Photo Credit: NASA The teams competed against entrepreneurs presenting their proposed solutions to tough technology challenges to judges consisting of NASA’s chief technologists, space industry leaders and potential investors. Hosted by the National Institute of Aerosp
Insulet to Assume Distribution and Commercial Support for Its Omnipod® System in Europe20.7.2017 20:01 | Pressemelding
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced plans to assume, on July 1, 2018, the distribution, sales, marketing, training and support activities of Insulet’s Omnipod System across Europe following the expiration of the Company’s global distribution agreement with Ypsomed AG (Ypsomed) on June 30, 2018. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170720006257/en/ Insulet develops, manufactures and distributes the Omnipod System, the market-leading tubeless insulin management system, currently used by over 110,000 people living with diabetes worldwide. Since 2010, the Company has had an exclusive contract with Ypsomed to distribute Insulet’s Omnipod System across Europe
Xilam: H1 2017 Revenue: +67%20.7.2017 16:00 | Pressemelding
Regulatory News: The Xilam Group (Paris:XIL) posted consolidated H1 2017 revenue of EUR 9.239 million, an increase of 67%. The revenue breakdown is as follows: In EUR 000 30.06.2017 (1) 30.06.2016 Change New productions(2) 4,571 4,036 +13.3% Catalogue 4,652
Natalia Vodianova Joins PicsArt as Head of Aspiration20.7.2017 13:00 | Pressemelding
PicsArt, the leading image editing app and creative social network, today announced the appointment of Natalia Vodianova, the supermodel and philanthropist, as Head of Aspiration. In this new role, Natalia will inspire and suggest opportunities to drive positive change through creativity. She has also joined the company’s advisory board. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170720005372/en/ Natalia Vodianova, the supermodel and philanthropist, joins PicsArt as Head of Aspiration. (Photo: Business Wire) “We are thrilled to welcome a talent and role model like Natalia into our family,” said PicsArt CEO Hovhannes Avoyan. “Natalia has been deeply involved in bringing creative inspiration to the world through fashion and social commitment. She’ll help connect the fashion world and the
Pacific Drilling Announces Early Consent Deadline Results20.7.2017 13:00 | Pressemelding
Pacific Drilling V Limited (the “Issuer”), a wholly owned subsidiary of Pacific Drilling S.A. (NYSE: PACD) (together with its subsidiaries, the “Company”) announced today the results, as of 5:00 p.m. Eastern Daylight Time on July 19 (the “Early Consent Deadline”) of its previously announced private consent solicitation in respect of its 7.25% Senior Secured Notes due December 1, 2017 (the “Notes”) pursuant to which the Issuer is soliciting the consent of the holders of Notes to an extension of the maturity date of the Notes to June 1, 2018 in order to give the Company more time to negotiate a refinancing transaction or undertake a holistic restructuring with all of its creditors (the “Solicitation”). At the Early Consent Deadline, the Issuer has received consents of holders of the Notes comprising less than 66 2/3% of the aggregate principal amount of the Notes (disregarding Notes held by the
CloudHealth Technologies Expands Business in Europe20.7.2017 13:00 | Pressemelding
CloudHealth Technologies, the leader in cloud service management, today announced that it is expanding its customer base, partner list and business operations in the European region. Helping to fuel the expansion is $46 million in Series D funding, which the company secured in June. The funding round will help CloudHealth Technologies scale international operations and double the size of its global workforce. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170720005189/en/ CloudHealth Technologies Expands Business in Europe (Photo: Business Wire) Cloud adoption in EMEA is growing steadily, with the market projected to reach €44.8 billion by the year 2020, according to Market Research & Statistics1. As enterprises turn to the cloud to build apps and manage operations, they improve
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom